THC Global Group moves to product validation ahead of medicinal cannabis supply
Imugene presents HER2 immuno-oncology vaccines success at ESMO ahead of 2020 studies
Kazia Therapeutics to share pipeline results with market and clinicians
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.